First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
IDRx Inc. - A GSK Company
IDRx Inc. - A GSK Company
Turning Point Therapeutics, Inc.
Stanford University
Theseus Pharmaceuticals
Hoffmann-La Roche
Novartis